Berkshire Aesthetics partners with BTL Industries for their range of energy-based devices treating a range of body issue

Dr Selena Langdon of Berkshire Aesthetics partners with BTL Industries becoming a Key Opinion Leader for their range of energy-based devices (Exilis Ultra & Unison) which treat a range of body issue including skin laxity, cellulite, stress incontinence and vaginal rejuvenation.

Dr Selena Langdon, the founder of Berkshire Aesthetics, which provides non-surgical aesthetic treatments, has agreed to work with BTL Industries and together have developed a key working relationship to increase the reputation of energy-based technology and the evidence behind them. Dr Langdon has introduced into her clinic several BTL devices including the Exilis Ultra, Ultra Femme 360 and the Unison. These devices use a combination of radio-frequency and ultrasound to address body and female intimate area concerns, are FDA cleared and leverage over 30 years’ experience which BTL has in the development of medical devices.

Dr Selena Langdon stated, “I am pleased to partner with BTL who have developed aesthetic devices which deliver the highest standard of patient safety and treatment efficacy. I am particularly impressed by their recent developments which combine formerly standalone treatment modalities thereby improving treatment outcomes. Having researched the options available to treat skin laxity, gynaecological issues and cellulite, the range of devices offered by BTL stood out as a clear choice”.

Matthew Hubball of BTL Industries commented on the partnership, “Dr Langdon has impressed us in terms of her approach to patient care and the treatment outcomes she is able to achieve with our devices. BTL Industries is excited to work with Dr Langdon and are pleased she will represent BTL at the upcoming FACE conference on the 15th of June in London”.

The partnership will mean Berkshire Aesthetics is able to access the latest technology developments from BTL while BTL will gain critical insight into the practical application of their devices in a clinical setting.

Press and media enquiries should be directed to:

Peter Langdon
Operations Director
Berkshire Aesthetics
Suite 1B, 1 Park Street
Maidenhead SL6 1SL

htps://www.berkshireaesthetics.com
peter@berkshireaesthetics.com
077 38 650 893